CIK: 0001560009
Total reported value
$141.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 54.44% | -0.16% | — | |
| 2 | BOLDEUR | Audentes Therapeutics INC | Stock-Other | 16.22% | — | — | |
| 3 | VCYT | Veracyte INC | Stock-Other | 11.75% | — | — | |
| 4 | OCUL | Ocular Therapeutix INC | Stock-Other | 5.18% | — | — | |
| 5 | CBAYUSD | Cymabay Therapeutics INC | Stock-Other | 4.09% | — | +3.44% | |
| 6 | ✓ | Second Sight Med Prods INC | Stock-Other | 2.90% | — | — | |
| 7 | IMRX | Immuneering Corporation | Stock-Other | 2.59% | — | — | |
| 8 | AKAOQ | Achaogen INC | Stock-Other | 1.74% | — | — | |
| 9 | CLVSEUR | Clovis Oncology INC | Stock-Other | 1.02% | — | — | |
| 10 | ✓ | Opgen, Inc. | Stock-Other | 0.07% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | BOLDEUR | Audentes Therapeutics INC | +1.9% | — | Unchanged |
| 2 | ✓ | Second Sight Med Prods INC | +0.6% | — | Unchanged |
| 3 | OCUL | Ocular Therapeutix INC | +0.5% | — | Unchanged |
| 4 | ✓ | Opgen, Inc. | 0% | — | Unchanged |
| 5 | CBAYUSD | Cymabay Therapeutics INC | -0.3% | +3.44% | Add |
| 6 | CLVSEUR | Clovis Oncology INC | -0.4% | — | Unchanged |
| 7 | IMRX | Immuneering Corporation | -0.5% | — | Unchanged |
| 8 | AKAOQ | Achaogen INC | -1.7% | — | Unchanged |
| 9 | CRSP | CRISPR Therapeutics AG | -11.7% | — | Unchanged |
| 10 | VCYT | Veracyte INC | — | NEW | New buy |